For Auld Lang Syne, my dear , for auld lang syne,I can tell ye ,that the next 4.5 months will be excitingt o say the least , to see the Biopharma space solidified within Ceapro. If ye thinks that is worth waiting for then just wait and see what 2021 brings. Aside from the fundamental transition from contract manufacturer to a true Biopharma company , you will likely have an elevated inflationary environment overall . Some of ye may recall the last time that we were in a truly elevated inflationary enivronment, it was the early 1980's. I can tell ye that Biotech were a haven.
Will Ceapro have a NASDAQ listing by year-end ? This is a great question .Let me say that there is no way that Ceapro will do a reverse split to get that NASDAQ listing by the end of the year .
And there's a hand my trusty friend! And give me a hand o'thine ! And we'll take a right good-will draught, FOR AULD LANG SYNE ! Doh !